Lithium, a common drug for bipolar disorder treatment, regulates amyloid-β precursor protein processing

Biochemistry

Volumn 43, Issue 22, 2004, Pages 6899-6908

  Su, Yuan ^a   Ryder, John ^a   Li, Baolin ^a   Wu, Xin ^a   Fox, Niles ^a   Solenberg, Pat ^a   Brune, Kellie ^a   Paul, Steven ^a,b   Zhou, Yan ^c   Liu, Feng ^c   Ni, Binhui ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Lilly Corporate Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; LITHIUM; NEUROLOGY; PATIENT TREATMENT; PROTEINS;

BIPOLAR DISORDERS; NEUROPROTECTIVE EFFECTS;

BIOCHEMISTRY;

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; LITHIUM CHLORIDE; VALPROIC ACID;

ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; BIPOLAR DISORDER; BRAIN TISSUE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MENTAL DISEASE; MOUSE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROCESSING; PSYCHOPHARMACOTHERAPY; SENILE PLAQUE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 2642552331     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi035627j     Document Type: Article

References (44)

1. Glenner, G. G., Wong, C. W., Quaranta, V., and Eanes, E. D. (1984) The amyloid deposits in Alzheimer's disease: Their nature and pathogenesis, Appl. Pathol. 2 (6), 357-369.
2. Selkoe, D. J., Abraham, C. R., Podlisny, M. B., and Duffy, L. K. (1986) Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease, J. Neurochem. 46 (6), 1820-1834.
3. Lee, E. B., Skovronsky, D. M., Abtahian, F., Doms, R. W., and Lee, V. M. (2003) Secretion and intracellular generation of truncated Aβ in β-site amyloid-β precursor protein-cleaving enzyme expressing human neurons, J. Biol. Chem. 278 (7), 4458-4466.
4. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics, Science 297 (5580), 353-356.
5. Kimberly, W. T., Xia, W., Rahmati, T., Wolfe, M. S., and Selkoe, D. J. (2000) The transmembrane aspartates in presenilin 1 and 2 are obligatory for γ-secretase activity and amyloid β-protein generation, J. Biol. Chem. 275 (5), 3173-3178.
6. Li, Y. M., Lai, M. T., Xu, M., Huang, Q., DiMuzio-Mower, J., Sardana, M. K., Shi, X. P., Yin, K. C., Shafer, J. A., and Gardell, S. J. (2000) Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state, Proc. Natl. Acad. Sci. U.S.A. 97 (11), 6138-6143.
7. Selkoe, D. J. (2001) Alzheimer's disease: Genes, proteins, and therapy, Physiol. Rev. 81 (2), 741-766.
8. De Strooper, B. (2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active γ-secretase complex, Neuron 38 (1), 9-12.
9. Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., and Wolozin, B. (1998) Presenilin 1 associates with glycogen synthase kinase-3β and its substrate τ, Proc. Natl. Acad. Sci. U.S.A. 95 (16), 9637-9641.
10. Tesco, G., and Tanzi, R. E. (2000) GSK3 β forms a tetrameric complex with endogenous PS1-CTF/NTF and β-catenin. Effects of the D257/D385A and FAD-linked mutations, Ann. N.Y. Acad. Sci. 920, 227-232.
11. Manji, H. K., Bebchuk, J. M., Moore, G. J., Glitz, D., Hasanat, K. A., and Chen, G. (1999) Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: Therapeutic implications, J. Clin. Psychiatry 60 (Suppl 2), 27-39, discussion 40-41 and 113-116.
12. Grimes, C. A., and Jope, R. S. (2001) The multifaceted roles of glycogen synthase kinase 3β in cellular signaling, Prog. Neurobiol. 65 (4), 391-426.
13. Hong, M., Chen, D. C., Klein, P. S., and Lee, V. M. (1997) Lithium reduces τ phosphorylation by inhibition of glycogen synthase kinase-3, J. Biol. Chem. 272 (40), 25326-25332.
14. Phiel, C. J., and Klein, P. S. (2001) Molecular targets of lithium action, Annu. Rev. Pharmacol. Toxicol. 41, 789-813.
15. Klein, P. S., and Melton, D. A. (1996) A molecular mechanism for the effect of lithium on development, Proc. Natl. Acad. Sci. U.S.A. 93 (16), 8455-8459.
16. Stambolic, V., Ruel, L., and Woodgett, J. R. (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells, Curr. Biol. 6 (12), 1664-1668.
17. Davies, S. P., Reddy, H., Caivano, M., and Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J. 351 (Part 1), 95-105.
18. Chen, G., Yuan, P. X., Jiang, Y. M., Huang, L. D., and Manji, H. K. (1999) Valproate robustly enhances AP-1 mediated gene expression, Mol. Brain Res. 64 (1), 52-58.
19. Berridge, M. J., Downes, C. P., and Hanley, M. R. (1989) Neural and developmental actions of lithium: A unifying hypothesis, Cell 59 (3), 411-419.
20. Hallcher, L. M., and Sherman, W. R. (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain, J. Biol. Chem. 255 (22), 10896-10901.
21. Klein, P. S., and Melton, D. A. (1996) A molecular mechanism for the effect of lithium on development, Proc. Natl. Acad. Sci. U.S.A. 93 (16), 8455-8459.
22. Dovey, H. F., John, V., Anderson, J. P., Chen, L. Z., de Saint Andrieu, P., Fang, L. Y., Freedman, S. B., Folmer, B., Goldbach, E., Holsztynska, E. J., Hu, K. L., Johnson-Wood, K. L., Kennedy, S. L., Kholodenko, D., Knops, J. E., Latimer, L. H., Lee, M., Liao, Z., Lieberburg, I. M., Motter, R. N., Mutter, L. C., Nietz, J., Quinn, K. P., Sacchi, K. L., Seubert, P. A., Shopp, G. M., Thorsett, E. D., Tung, J. S., Wu, J., Yang, S., Yin, C. T., Schenk, D. B., May, P. C., Altstiel, L. D., Bender, M. H., Boggs, L. N., Britton, T. C., Clemens, J. C., Czilli, D. L., Dieckman-McGinty, D. K., Droste, J. J., Fuson, K. S., Gitter, B. D., Hyslop, P. A., Johnstone, E. M., Li, W. Y., Little, S. P., Mabry, T. E., Miller, F. D., and Audia, J. E. (2001) Functional γ-secretase inhibitors reduce β-amyloid peptide levels in brain, J. Neurochem. 76 (1), 173-181.
23. Eckel, L. A., and Ossenkopp, K. P. (1993) Novel diet consumption and body weight gain are reduced in rats chronically infused with lithium chloride: Mediation by the chemosensifive area postrema, Brain Res. Bull. 31 (5), 613-619.
24. Fox, N., and Solter, D. (1988) Expression and regulation of the pituitary- and placenta-specific human glycoprotein hormone α-subunit gene is restricted to the pituitary in transgenic mice, Mol. Cell. Biol. 8 (12), 5470-5476.
25. Sasahara, M., Fries, J. W., Raines, E. W., Gown, A. M., Westrum, L. E., Frosch, M. P., Bonthron, D. T., Ross, R., and Collins, T. (1991) PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model, Cell 64 (1), 217-227.
26. Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., and Younkin, S. G. (2001) Age-dependent changes in brain, CSF, and plasma amyloid (β) protein in the Tg2576 transgenic mouse model of Alzheimer's disease, J. Neurosci. 21 (2), 372-381.
27. Liu, F., Su, Y., Li, B., and Ni, B. (2003) Regulation of amyloid precursor protein expression and secretion via activation of ERK 1/2 by hepatocyte growth factor in HEK293 cells transfected with APP751, Exp. Cell Res. 287 (2), 387-396.
28. Eldar-Finkelman, H., Argast, G. M., Foord, O., Fischer, E. H., and Krebs, E. G. (1996) Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells, Proc. Natl. Acad. Sci. U.S.A. 93 (19), 10228-10233.
29. Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., and Freier, S. M. (1993) Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression, J. Biol. Chem. 268 (19), 14514-14522.
30. Li, B., Su, Y., Ryder, J., Yan, L., Na, S., and Ni, B. (2003) RIFLE: A novel ring zinc finger-leucine-rich repeat containing protein, regulates select cell adhesion molecules in PC12 cells, J. Cell. Biochem. 90 (6), 1224-1241.
31. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids, Nature 359 (6393), 325-327.
32. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein, Nature 373 (6514), 523-527.
33. Su, Y., and Ni, B. (1998) Selective deposition of amyloid-β protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease, J. Neurosci. Res. 53 (2), 177-186.
34. Mora, A., Sabio, G., Risco, A. M., Cuenda, A., Alonso, J. C., Soler, G., and Centeno, F. (2002) Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A, Cell Signalling 14 (6), 557-562.
35. Rossig, L., Badorff, C., Holzmann, Y., Zeiher, A. M., and Dimmeler, S. (2002) Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation, J. Biol. Chem. 277 (12), 9684-9689.
36. Sun, X., Sato, S., Murayama, O., Murayama, M., Park, J. M., Yamaguchi, H., and Takashima, A. (2002) Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100, Neurosci. Lett. 321 (1-2), 61-64.
37. Chen, G., Yuan, P. X., Jiang, Y. M., Huang, L. D., and Manji, H. K. (1998) Lithium increases tyrosine hydroxylase levels both in vivo and in vitro, J. Neurochem. 70 (4), 1768-1771.
38. Phiel, C. J., Wilson, C. A., Lee, V. M., and Klein, P. S. (2003) GSK-3α regulates production of Alzheimer's disease amyloid-β peptides, Nature 423 (6938), 435-439.
39. Brownlees, J., Irving, N. G., Brion, J. P., Gibb, B. J., Wagner, U., Woodgett, J., and Miller, C. C. (1997) τ phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes, NeuroReport 8 (15), 3251-3255.
40. Lucas, J. J., Hernandez, F., Gomez-Ramos, P., Moran, M. A., Hen, R., and Avila, J. (2001) Decreased nuclear β-catenin, τ hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice, EMBO J. 20 (1-2), 27-39.
41. Nuydens, R., Van Den Kieboom, G., Nolten, C., Verhulst, C., Van Osta, P., Spittaels, K., Van den Haute, C., De Feyter, E., Geerts, H., and Van Leuven, F. (2002) Coexpression of GSK-3β corrects phenotypic aberrations of dorsal root ganglion cells, cultured from adult transgenic mice overexpressing human protein τ, Neurobiol. Dis. 9 (1), 38-48.
42. Spittaels, K., Van den Haute, C., Van Dorpe, J., Terwel, D., Vandezande, K., Lasrado, R., Bruynseels, K., Irizarry, M., Verhoye, M., Van Lint, J., Vandenheede, J. R., Ashton, D., Mercken, M., Loos, R., Hyman, B., Van der Linden, A., Geerts, H., and Van Leuven, F. (2002) Neonatal neuronal overexpression of glycogen synthase kinase-3 β reduces brain size in transgenic mice, Neuroscience 113 (4), 797-808.
43. Hedgepeth, C. M., Conrad, L. J., Zhang, J., Huang, H. C., Lee, V. M., and Klein, P. S. (1997) Activation of the Wnt signaling pathway: A molecular mechanism for lithium action, Dev. Biol. 185 (1), 82-91.
44. Choi, W. S., and Sung, C. K. (2000) Effects of lithium and insulin on glycogen synthesis in L6 myocytes: Additive effects on inactivation of glycogen synthase kinase-3, Biochim. Biophys. Acta 1475 (3), 225-230.